pharmaphorum

OCTOBER 1, 2020

Adalimumab – sold by AbbVie as Humira as well as in biosimilar form by companies including Novartis’ Sandoz unit, Amgen and Biogen/Samsung joint venture Bioepis – will be used in the phase 2 AVID-CC study to see if it can prevent progression to respiratory failure in people with coronavirus infections.

Biosimilars 90

Biosimilars Hospitals Inpatient 90

Putting Patients First Blog

DECEMBER 9, 2024

CMS is proposing setting a 20% coinsurance/equivalent copayment limit for behavioral health services, eliminating cost-sharing for opioid treatment program services, and capping inpatient psychiatric service cost sharing to 100% of Medicare Fee-For-Services levels.

Medication Therapy Management (MTM) 52

Medication Therapy Management (MTM) Biosimilars Inpatient Communication 52

FDA Law Blog: Biosimilars

SEPTEMBER 30, 2024

physicians services or inpatient hospitals services) and for which Medicaid payment may be made as part of payment for the service “and not as direct reimbursement for the drug.” 1396r-8(k)(3).

Vaccines 59

Vaccines Inpatient Packaging Documentation 59

FDA Law Blog: Biosimilars

APRIL 8, 2024

To address the underlying causes of shortages, the White Paper suggests that the creation (by Congress) of two programs that link inpatient hospital purchasing and payment decisions to supply chain resilience practices would better incentivize investments in mature manufacturing practices.

Inpatient 59

Inpatient Hospitals Dosage Controlled Substances 59

RX Note

FEBRUARY 23, 2023

. - Drug registration number Medicines (Advertisement & Sale) Act 1956 and Regulations - To learn prohibitions of medicine advertisement and Medicine Advertisement Board Registration of Pharmacists Act 1951 and Regulations - Pharmacy Board Malaysia and legislation aspects of provisional, full and temporary registration Code of Ethics for Pharmacists (..)

HIV Treatment and Prevention Agents 58

HIV Treatment and Prevention Agents Community Pharmacies Labelling Chemotherapy 58

FDA Law Blog: Biosimilars

MARCH 6, 2025

inpatient hospital, out-patient clinic), date range for the data, and location of the data collection sites (e.g., OUS data may introduce bias if the OUS population does not reflect the U.S. population due to differences in demographics, practice of medicine, or standard of care. The DCP may also define the sources of the data (e.g.,

Documentation 59

Documentation Inpatient Labelling Hospitals 59